Recommendations for asthma monitoring in children: A PeARL document endorsed by APAPARI, EAACI, INTERASMA, REG, and WAO.
Papadopoulos G NikolaosAdnan CustovicAntoine DeschildreJames E GernAntonio Nieto GarciaMichael MiligkosWanda PhipatanakulGary Wing Kin WongParaskevi XepapadakiIoana AgacheStefania ArasiZeinab Awad El-SayedLeonard B BacharierMatteo BoniniFulvio BraidoDavide Paolo CaimmiJose A Castro-RodriguezZhi-Min ChenMichael ClausenTimothy CraigZuzana DiamantFrancine M DucharmeMotohiro EbisawaPhilippe A EigenmannWojciech FeleszkoVincezo FierroAlessandro Giovanni FiocchiGarcía-Marcos LuisAnne GohRené Maximiliano GómezMaia GotuaEckard HamelmannGunilla HedlinElham M HossnyZhanat IspayevaDaniel J JacksonTuomas JarttiJesenak MilosOmer KalayciAlan KaplanJon R KonradsenPiotr KunaSusanne LauPeter Le SouefRobert F LemanskeMichael Eliad LevinMika J MakelaAlexander G MathioudakisOleksandr MazulovMário Morais-AlmeidaClare MurrayKarthik NagarajuZoltan NovakRuby PawankarMarielle W PijnenburgHelena PitePaulo M PitrezPetr PohunekDavid J PriceAlfred PriftanjiValeria RamiconiDaniela Rivero-YeverinoGraham C RobertsAziz SheikhKun-Ling ShenZsolt SzépfalusiIoanna TsiligianniMirjana TurkaljStephen W TurnerTetiana UmanetsArunas ValiulisSusanne VijvebergJiu-Yao WangTonya WindersDong-Keon YonOsman M YusufHeather J Zarnull nullPublished in: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology (2024)
Monitoring is a major component of asthma management in children. Regular monitoring allows for diagnosis confirmation, treatment optimization, and natural history review. Numerous factors that may affect disease activity and patient well-being need to be monitored: response and adherence to treatment, disease control, disease progression, comorbidities, quality of life, medication side-effects, allergen and irritant exposures, diet and more. However, the prioritization of such factors and the selection of relevant assessment tools is an unmet need. Furthermore, rapidly developing technologies promise new opportunities for closer, or even "real-time," monitoring between visits. Following an approach that included needs assessment, evidence appraisal, and Delphi consensus, the PeARL Think Tank, in collaboration with major international professional and patient organizations, has developed a set of 24 recommendations on pediatric asthma monitoring, to support healthcare professionals in decision-making and care pathway design.
Keyphrases
- disease activity
- chronic obstructive pulmonary disease
- rheumatoid arthritis
- systemic lupus erythematosus
- allergic rhinitis
- healthcare
- decision making
- case report
- clinical practice
- emergency department
- physical activity
- type diabetes
- rheumatoid arthritis patients
- adipose tissue
- cystic fibrosis
- replacement therapy
- artificial intelligence
- insulin resistance
- adverse drug
- clinical evaluation